Mchugh Julie
SEC-identified person · CIK 1487179 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Ironwood Pharmaceuticals INC IRWD | Director | filed 2014–2026 |
| Lantheus Holdings, Inc. LNTH | Director | filed 2017–2026 |
| Evelo Biosciences, Inc. EVLO | Director | filed 2021–2023 |
| Aerie Pharmaceuticals INC AERI | Director | filed 2015–2022 |
| Trevena INC TRVN | Director | filed 2014–2020 |
| Zalicus Inc. ZLCS | Director | filed 2014–2015 |
| Viropharma INC VPHM | Director | filed 2012–2014 |
| Endo Pharmaceuticals Holdings INC ENDP | Chief Operating Officer | filed 2010–2013 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.